Skip to main content

Nephros Inc

NEPH
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001196298

In the last 90 days, Nephros Inc insiders filed 1 open-market purchase and 0 sales; 35 institutions reported holding it in 13F filings for Q3 2026, worth $9.54M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Nephros Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
1 filing
1 insider, $22.1K in total
Open-market sells
0 filings
Insiders trading
1
Net value
+$22.1K
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Nephros Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Nephros Inc
NameTitleLast reported holdingLast filingFilings, past year
Amron Arthur HDirector169,637Nov 18, 20266
Spandow Oliver J.Director126,797Nov 12, 20261
Davidson Charles E10% Owner166,667IndirectSep 16, 20262
Wexford Capital LP10% Owner166,667IndirectSep 16, 20262
Jacobs Joseph10% Owner166,667IndirectSep 16, 20262
Wexford GP LLC10% Owner166,667IndirectSep 16, 20262
Amron Holdings LLCDirector25,546IndirectSep 16, 20261
Krandel JudyChief Financial Officer68,861Mar 25, 20262
Banks Robert R. Jr.President and CEO190,000Mar 25, 20261
Nettis Lisa MarieDirector1,622Nov 13, 20250
Lask AlisaDirector48,629Jan 3, 20250
Harris Joseph MichaelDirector17,693Jan 3, 20250
Gwydir TomDirector43,226Jan 9, 20230
Astor AndrewPresident, CEO & CFO92,773Mar 7, 20220
Lobo Wesley S.Chief Marketing Officer35,168Feb 18, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 18, 2026 (view filing)4:57 PM ETNov 16-172 daysAmron Arthur HDirectorPPurchase+7.50K$2.94+$22.1K+4.6%169.6K after2 lots
May 30, 2024 (view filing)May 28-302 daysAmron Arthur HDirectorPPurchase+5.00K$2.23+$11.2K+5.1%103.5K after2 lots
May 16, 2024 (view filing)May 16Same dayBanks Robert R. Jr.President and CEOPPurchase+50.0K$2.24+$112.0K+250.0%70.0K after
Mar 14, 2024 (view filing)Mar 122 daysAmron Arthur HDirectorPPurchase+7.00K$2.45+$17.1KNew position7.00K after
Dec 11, 2023 (view filing)Dec 74 daysBanks Robert R. Jr.President and CEOPPurchase+18.0K$2.20+$39.6K+900.0%20.0K after
Aug 15, 2023 (view filing)Aug 14-151 dayBanks Robert R. Jr.President and CEOPPurchase+2.00K$1.68+$3.36KNew position2.00K after2 lots
Aug 23, 2021 (view filing)Aug 203 daysLobo Wesley S.Chief Marketing OfficerPPurchase+1.00K$7.92+$7.92K+2.5%41.6K after
Aug 19, 2021 (view filing)Aug 181 dayGwydir TomDirectorPPurchase+5.00K$7.64+$38.2K+82.9%11.0K after
Aug 18, 2021 (view filing)Aug 17-181 dayAstor AndrewPresident & CEOPPurchase+5.00K$7.72+$38.6K+6.9%78.0K after2 lots